Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions
Ying Han, Kai Yuan, Zhe Wang, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2
Lisa Bauer, Brigitta M. Laksono, Femke M.S. de Vrij, et al.
Trends in Neurosciences (2022) Vol. 45, Iss. 5, pp. 358-368
Open Access | Times Cited: 190
COVID-19 in pregnancy: implications for fetal brain development
Lydia L. Shook, Elinor L. Sullivan, Jamie O. Lo, et al.
Trends in Molecular Medicine (2022) Vol. 28, Iss. 4, pp. 319-330
Open Access | Times Cited: 118
Long COVID and neuropsychiatric manifestations (Review)
Vasiliki Efstathiou, Maria‐Ioanna Stefanou, Marina Demetriou, et al.
Experimental and Therapeutic Medicine (2022) Vol. 23, Iss. 5
Open Access | Times Cited: 76
Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an update
Sizhen Su, Yi‐Miao Zhao, Na Zeng, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 10, pp. 4056-4069
Closed Access | Times Cited: 62
Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID
Theoharis C. Theoharides, Duraisamy Kempuraj
Cells (2023) Vol. 12, Iss. 5, pp. 688-688
Open Access | Times Cited: 53
Alteration of the blood-brain barrier by COVID-19 and its implication in the permeation of drugs into the brain
Héctor Hernández‐Parra, Octavio D. Reyes‐Hernández, Gabriela Figueroa‐González, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 30
Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease
Hiam Naiditch, Michael R. Betts, H. Benjamin Larman, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Multi-target drugs for the treatment of cognitive impairment and fatigue in post-COVID syndrome: focus on Ginkgo biloba and Rhodiola rosea
Juliane K. Mueller, Walter E. Müller
Journal of Neural Transmission (2024) Vol. 131, Iss. 3, pp. 203-212
Open Access | Times Cited: 6
Monitoring cognitive and psychological alterations in COVID-19 patients: A longitudinal neuropsychological study
Lorenzo Diana, Rossana Regazzoni, Matteo Sozzi, et al.
Journal of the Neurological Sciences (2022) Vol. 444, pp. 120511-120511
Open Access | Times Cited: 25
“We Were Afraid”: Mental Health Effects of the COVID-19 Pandemic in Two South African Districts
Teurai Rwafa-Ponela, Jessica Price, Athini Nyatela, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 15, pp. 9217-9217
Open Access | Times Cited: 23
Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes
Matthew P. Lennol, Nicholas J. Ashton, Óscar Moreno, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2715-2715
Open Access | Times Cited: 15
Mental health, sleep, and respiratory health after initiating elexacaftor/tezacaftor/ivacaftor treatment in children with cystic fibrosis
Hiep Pham, Moya Vandeleur, Rheanna Mainzer, et al.
Pediatric Pulmonology (2024)
Open Access | Times Cited: 5
The contribution of gut-brain axis to development of neurological symptoms in COVID-19 recovered patients: A hypothesis and review of literature
Kimia Vakili, Mobina Fathi, Shirin Yaghoobpoor, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 20
Brain disorders: Impact of mild SARS-CoV-2 may shrink several parts of the brain
Puranam Revanth Kumar, B. Shilpa, Rajesh Kumar Jha
Neuroscience & Biobehavioral Reviews (2023) Vol. 149, pp. 105150-105150
Open Access | Times Cited: 11
Non-coding RNAs expression in SARS-CoV-2 infection: Pathogenesis, clinical significance and therapeutic targets
Xiaoxing Liu, Wandi Xiong, Maosen Ye, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 11
Acute Schizophrenia-like Psychotic Disorder Against the Background of COVID-19
L. V. Bravve, Maria Kaydan, G. P. Kostyuk
Medicina (2025) Vol. 61, Iss. 2, pp. 298-298
Open Access
Neurofilament light chain as a biomarker for neurodegenerative changes in COVID-19 and clinical implications
Yousef Rasmi, Yeganeh Farnamian, Marijana Marković Boras, et al.
Future Virology (2025), pp. 1-15
Closed Access
SARS-CoV-2 and the central nervous system: Emerging insights into hemorrhage-associated neurological consequences and therapeutic considerations
Joy Mitra, Manohar Kodavati, Vincent E. Provasek, et al.
Ageing Research Reviews (2022) Vol. 80, pp. 101687-101687
Open Access | Times Cited: 16
A Comprehensive Review on Navigating the Neurological Landscape of COVID-19: Insights Into Etiopathogenesis and Clinical Management
Roma Chavhan, Anil Wanjari, Sunil Kumar, et al.
Cureus (2024)
Open Access | Times Cited: 3
Cognitive impairment in health care workers recovering from COVID-19 infection: a cross-sectional comparative study
Ahmed Khaled Abd-Elrazzak Omar, Salwa M. A. Dahesh, Doha El‐Sayed Ellakwa, et al.
Middle East Current Psychiatry (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 14
Schizophrenia and the COVID-19 pandemic: A narrative review from the biomedical perspective
Krzysztof Kowalski, Błażej Misiak
Revista de Psiquiatría y Salud Mental (2023)
Closed Access | Times Cited: 5
Neuronal and Non-Neuronal GABA in COVID-19: Relevance for Psychiatry
Adonis Sfera, Karina G. Thomas, Sarvin Sasannia, et al.
Reports — Medical Cases Images and Videos (2022) Vol. 5, Iss. 2, pp. 22-22
Open Access | Times Cited: 8
COVID‑19‑related psychiatric manifestations requiring hospitalization: Analysis in older vs. younger patients
Fabiola Sârbu, Violeta Diana Oprea, Alin Laurenţiu Tatu, et al.
Experimental and Therapeutic Medicine (2022) Vol. 24, Iss. 2
Open Access | Times Cited: 8
Unmasking the long-term effects: unravelling neuropsychiatric and neurological consequences of COVID-19
Mahnoor Tariq, FNU Mahak, Rahul Kumar, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 3, pp. 1490-1495
Open Access | Times Cited: 1
An overview of post COVID sequelae
Ajay Kumar Shukla, Saurav Misra
Journal of Basic and Clinical Physiology and Pharmacology (2022) Vol. 33, Iss. 6, pp. 715-726
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top